Akero Therapeutics, Inc. acquired by Novo Nordisk for up to $5.2 billion, driven by strong phase 2b results for EFX. Read ...

Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone ...

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver ...

NEW YORK, NEW YORK - JUNE 21: Dan Marino speaks onstage at Fanatics Fest NYC 2025 at Javits Center on June 21, 2025 in New York City. (Photo by Slaven Vlasic/Getty Images) To say that Dan Marino has ...

Pro Football Hall of Famer and Miami Dolphins legend Dan Marino had a wake-up call in 2007 when he received a personal health diagnosis. Now, he’s sharing his journey to help others who may be ...

Apple this month expanded its music transfer tool to almost all countries where Apple Music is supported, simplifying the transition from services like Spotify to ‌Apple Music‌. The transfer tool lets ...

MASH affects over 250 million globally, with advanced cases expected to double by 2030 due to underlying conditions like obesity and metabolic syndrome. Recent FDA and EMA approvals of Rezdiffra and ...

The last time I spoke about 89bio (NASDAQ:ETNB) it was with respect to a Seeking Alpha article entitled "89bio: Advancement Of Pegozafermin For SHTG Is Another Path Forward." With respect to this ...

Google's Gemini Nano Banana AI tool has sparked viral trends like 3D figurines and Bollywood-style saree transformations. While Google implements watermarks for AI-generated content, experts warn ...

A Black student was found hanging from a tree. Police say there's no sign of foul play The Netflix Secret Codes That Reveal Thousands of Hidden Movies iPhones Have A Built-In Motion Sickness Feature ...

The book report is now a thing of the past. Take-home tests and essays are becoming obsolete. Student use of artificial intelligence has become so prevalent, high school and college educators say, ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...